---
title: "Rockwell Automation, Inc. Stock 12‑Month Price Target Raised to $467.39, Implies 4% Upside"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286632993.md"
description: "Rockwell Automation, Inc.'s stock price target has been raised to $467.39, indicating a potential upside of 4%. This adjustment comes from 23 analysts, with price forecasts ranging from $378 to $525. The consensus rating remains 'Buy' with 14 Buys, 15 Holds, and 1 Sell."
datetime: "2026-05-16T04:20:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286632993.md)
  - [en](https://longbridge.com/en/news/286632993.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286632993.md)
---

# Rockwell Automation, Inc. Stock 12‑Month Price Target Raised to $467.39, Implies 4% Upside

-   According to estimates from 23 analysts, Rockwell Automation, Inc. stock's average price target has risen from $464 to $467.39, with forecasts ranging from $378 to $525 per share
-   Based on the May 15 closing price, the updated target implies approximately 4% potential upside
-   Consensus rating remains at “Buy” across 30 covering analysts, with 14 Buys, 15 Holds and 1 Sells

Explore more price target data and ratings for Rockwell Automation, Inc. on the , and track all previous and future analyst recommendations for Rockwell Automation, Inc. in the dedicated News Flow.

**Disclaimer**

Select reference data provided by FactSet. Copyright © 2026 FactSet Research Systems Inc. This information is not a recommendation for what you should do personally and does not constitute investment advice.

### Related Stocks

- [ROK.US](https://longbridge.com/en/quote/ROK.US.md)

## Related News & Research

- [Rockwell Slides Despite Boosting Climate Commitment](https://longbridge.com/en/news/286437128.md)
- [CORDA Investment Management LLC. Acquires New Position in Rockwell Automation, Inc. $ROK](https://longbridge.com/en/news/285688516.md)
- [The S&P 500 Just Completed Its 7th Straight Up Week. History Says It's Still Time to Buy.](https://longbridge.com/en/news/287006210.md)
- [Assessing BioMarin Pharmaceutical (BMRN) Valuation After Prolonged Share Price Weakness](https://longbridge.com/en/news/286895616.md)
- [Buckle (BKE) Valuation Check After Updated Sales And Ongoing Net Sales Momentum](https://longbridge.com/en/news/286843012.md)